Structure Therapeutics Inc. announced that at the AGM held on June 25, 2024, approved the appointment of Ted W. Love, M.D. to the Audit Committee.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.34 USD | -14.15% |
|
-8.34% | -5.94% |
27/06 | Structure Therapeutics Inc. Appoints Ted W. Love as to the Audit Committee | CI |
07/06 | Structure Therapeutics Closes $547.4 Million Offering | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.94% | 208.21Cr | |
+20.03% | 13TCr | |
+23.61% | 12TCr | |
+23.26% | 2.79TCr | |
-18.07% | 2.1TCr | |
-15.13% | 1.69TCr | |
-14.81% | 1.62TCr | |
+9.78% | 1.48TCr | |
-46.10% | 1.48TCr | |
+52.34% | 1.41TCr |
- Stock Market
- Equities
- GPCR Stock
- News Structure Therapeutics Inc.
- Structure Therapeutics Inc. Appoints Ted W. Love as to the Audit Committee